Global Vildagliptin Market Growth 2025-2031
The global Vildagliptin market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
White or off white crystalline powder,CAS no. is 274901-16-5 and molecular formula is C17H25N3O2.
United States market for Vildagliptin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Vildagliptin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Vildagliptin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Vildagliptin players cover Hikal, Jubilant Pharma, Glenmark Life Sciences, Chengda Pharmaceuticals, Fuxin Longrui Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Vildagliptin Industry Forecast” looks at past sales and reviews total world Vildagliptin sales in 2024, providing a comprehensive analysis by region and market sector of projected Vildagliptin sales for 2025 through 2031. With Vildagliptin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vildagliptin industry.
This Insight Report provides a comprehensive analysis of the global Vildagliptin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vildagliptin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vildagliptin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vildagliptin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vildagliptin.
This report presents a comprehensive overview, market shares, and growth opportunities of Vildagliptin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Vildagliptin market?
What factors are driving Vildagliptin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vildagliptin market opportunities vary by end market size?
How does Vildagliptin break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
White or off white crystalline powder,CAS no. is 274901-16-5 and molecular formula is C17H25N3O2.
United States market for Vildagliptin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Vildagliptin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Vildagliptin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Vildagliptin players cover Hikal, Jubilant Pharma, Glenmark Life Sciences, Chengda Pharmaceuticals, Fuxin Longrui Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Vildagliptin Industry Forecast” looks at past sales and reviews total world Vildagliptin sales in 2024, providing a comprehensive analysis by region and market sector of projected Vildagliptin sales for 2025 through 2031. With Vildagliptin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vildagliptin industry.
This Insight Report provides a comprehensive analysis of the global Vildagliptin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vildagliptin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vildagliptin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vildagliptin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vildagliptin.
This report presents a comprehensive overview, market shares, and growth opportunities of Vildagliptin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Purity?98%
- Purity?99%
- Vildagliptin Tablets
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Hikal
- Jubilant Pharma
- Glenmark Life Sciences
- Chengda Pharmaceuticals
- Fuxin Longrui Pharmaceutical
- Jiangxi Synergy Pharma
- JSC Olainfarm
- Century Pharmaceuticals
- Metrochem
- TAGOOR LABORATORIES
- Biocon
- Kimia Biosciences
- Lee Pharma
- Viwit
- Shanghai Acebright
- Ningbo Menovo Pharma
- Hangzhou Longshine Bio-Tech
What is the 10-year outlook for the global Vildagliptin market?
What factors are driving Vildagliptin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vildagliptin market opportunities vary by end market size?
How does Vildagliptin break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vildagliptin Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Vildagliptin by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Vildagliptin by Country/Region, 2020, 2024 & 2031
2.2 Vildagliptin Segment by Type
2.2.1 Purity?98%
2.2.2 Purity?99%
2.3 Vildagliptin Sales by Type
2.3.1 Global Vildagliptin Sales Market Share by Type (2020-2025)
2.3.2 Global Vildagliptin Revenue and Market Share by Type (2020-2025)
2.3.3 Global Vildagliptin Sale Price by Type (2020-2025)
2.4 Vildagliptin Segment by Application
2.4.1 Vildagliptin Tablets
2.4.2 Other
2.5 Vildagliptin Sales by Application
2.5.1 Global Vildagliptin Sale Market Share by Application (2020-2025)
2.5.2 Global Vildagliptin Revenue and Market Share by Application (2020-2025)
2.5.3 Global Vildagliptin Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Vildagliptin Breakdown Data by Company
3.1.1 Global Vildagliptin Annual Sales by Company (2020-2025)
3.1.2 Global Vildagliptin Sales Market Share by Company (2020-2025)
3.2 Global Vildagliptin Annual Revenue by Company (2020-2025)
3.2.1 Global Vildagliptin Revenue by Company (2020-2025)
3.2.2 Global Vildagliptin Revenue Market Share by Company (2020-2025)
3.3 Global Vildagliptin Sale Price by Company
3.4 Key Manufacturers Vildagliptin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vildagliptin Product Location Distribution
3.4.2 Players Vildagliptin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VILDAGLIPTIN BY GEOGRAPHIC REGION
4.1 World Historic Vildagliptin Market Size by Geographic Region (2020-2025)
4.1.1 Global Vildagliptin Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Vildagliptin Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Vildagliptin Market Size by Country/Region (2020-2025)
4.2.1 Global Vildagliptin Annual Sales by Country/Region (2020-2025)
4.2.2 Global Vildagliptin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Vildagliptin Sales Growth
4.4 APAC Vildagliptin Sales Growth
4.5 Europe Vildagliptin Sales Growth
4.6 Middle East & Africa Vildagliptin Sales Growth
5 AMERICAS
5.1 Americas Vildagliptin Sales by Country
5.1.1 Americas Vildagliptin Sales by Country (2020-2025)
5.1.2 Americas Vildagliptin Revenue by Country (2020-2025)
5.2 Americas Vildagliptin Sales by Type (2020-2025)
5.3 Americas Vildagliptin Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vildagliptin Sales by Region
6.1.1 APAC Vildagliptin Sales by Region (2020-2025)
6.1.2 APAC Vildagliptin Revenue by Region (2020-2025)
6.2 APAC Vildagliptin Sales by Type (2020-2025)
6.3 APAC Vildagliptin Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vildagliptin by Country
7.1.1 Europe Vildagliptin Sales by Country (2020-2025)
7.1.2 Europe Vildagliptin Revenue by Country (2020-2025)
7.2 Europe Vildagliptin Sales by Type (2020-2025)
7.3 Europe Vildagliptin Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vildagliptin by Country
8.1.1 Middle East & Africa Vildagliptin Sales by Country (2020-2025)
8.1.2 Middle East & Africa Vildagliptin Revenue by Country (2020-2025)
8.2 Middle East & Africa Vildagliptin Sales by Type (2020-2025)
8.3 Middle East & Africa Vildagliptin Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vildagliptin
10.3 Manufacturing Process Analysis of Vildagliptin
10.4 Industry Chain Structure of Vildagliptin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vildagliptin Distributors
11.3 Vildagliptin Customer
12 WORLD FORECAST REVIEW FOR VILDAGLIPTIN BY GEOGRAPHIC REGION
12.1 Global Vildagliptin Market Size Forecast by Region
12.1.1 Global Vildagliptin Forecast by Region (2026-2031)
12.1.2 Global Vildagliptin Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Vildagliptin Forecast by Type (2026-2031)
12.7 Global Vildagliptin Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Hikal
13.1.1 Hikal Company Information
13.1.2 Hikal Vildagliptin Product Portfolios and Specifications
13.1.3 Hikal Vildagliptin Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Hikal Main Business Overview
13.1.5 Hikal Latest Developments
13.2 Jubilant Pharma
13.2.1 Jubilant Pharma Company Information
13.2.2 Jubilant Pharma Vildagliptin Product Portfolios and Specifications
13.2.3 Jubilant Pharma Vildagliptin Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Jubilant Pharma Main Business Overview
13.2.5 Jubilant Pharma Latest Developments
13.3 Glenmark Life Sciences
13.3.1 Glenmark Life Sciences Company Information
13.3.2 Glenmark Life Sciences Vildagliptin Product Portfolios and Specifications
13.3.3 Glenmark Life Sciences Vildagliptin Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Glenmark Life Sciences Main Business Overview
13.3.5 Glenmark Life Sciences Latest Developments
13.4 Chengda Pharmaceuticals
13.4.1 Chengda Pharmaceuticals Company Information
13.4.2 Chengda Pharmaceuticals Vildagliptin Product Portfolios and Specifications
13.4.3 Chengda Pharmaceuticals Vildagliptin Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Chengda Pharmaceuticals Main Business Overview
13.4.5 Chengda Pharmaceuticals Latest Developments
13.5 Fuxin Longrui Pharmaceutical
13.5.1 Fuxin Longrui Pharmaceutical Company Information
13.5.2 Fuxin Longrui Pharmaceutical Vildagliptin Product Portfolios and Specifications
13.5.3 Fuxin Longrui Pharmaceutical Vildagliptin Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Fuxin Longrui Pharmaceutical Main Business Overview
13.5.5 Fuxin Longrui Pharmaceutical Latest Developments
13.6 Jiangxi Synergy Pharma
13.6.1 Jiangxi Synergy Pharma Company Information
13.6.2 Jiangxi Synergy Pharma Vildagliptin Product Portfolios and Specifications
13.6.3 Jiangxi Synergy Pharma Vildagliptin Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Jiangxi Synergy Pharma Main Business Overview
13.6.5 Jiangxi Synergy Pharma Latest Developments
13.7 JSC Olainfarm
13.7.1 JSC Olainfarm Company Information
13.7.2 JSC Olainfarm Vildagliptin Product Portfolios and Specifications
13.7.3 JSC Olainfarm Vildagliptin Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 JSC Olainfarm Main Business Overview
13.7.5 JSC Olainfarm Latest Developments
13.8 Century Pharmaceuticals
13.8.1 Century Pharmaceuticals Company Information
13.8.2 Century Pharmaceuticals Vildagliptin Product Portfolios and Specifications
13.8.3 Century Pharmaceuticals Vildagliptin Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Century Pharmaceuticals Main Business Overview
13.8.5 Century Pharmaceuticals Latest Developments
13.9 Metrochem
13.9.1 Metrochem Company Information
13.9.2 Metrochem Vildagliptin Product Portfolios and Specifications
13.9.3 Metrochem Vildagliptin Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Metrochem Main Business Overview
13.9.5 Metrochem Latest Developments
13.10 TAGOOR LABORATORIES
13.10.1 TAGOOR LABORATORIES Company Information
13.10.2 TAGOOR LABORATORIES Vildagliptin Product Portfolios and Specifications
13.10.3 TAGOOR LABORATORIES Vildagliptin Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 TAGOOR LABORATORIES Main Business Overview
13.10.5 TAGOOR LABORATORIES Latest Developments
13.11 Biocon
13.11.1 Biocon Company Information
13.11.2 Biocon Vildagliptin Product Portfolios and Specifications
13.11.3 Biocon Vildagliptin Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Biocon Main Business Overview
13.11.5 Biocon Latest Developments
13.12 Kimia Biosciences
13.12.1 Kimia Biosciences Company Information
13.12.2 Kimia Biosciences Vildagliptin Product Portfolios and Specifications
13.12.3 Kimia Biosciences Vildagliptin Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Kimia Biosciences Main Business Overview
13.12.5 Kimia Biosciences Latest Developments
13.13 Lee Pharma
13.13.1 Lee Pharma Company Information
13.13.2 Lee Pharma Vildagliptin Product Portfolios and Specifications
13.13.3 Lee Pharma Vildagliptin Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Lee Pharma Main Business Overview
13.13.5 Lee Pharma Latest Developments
13.14 Viwit
13.14.1 Viwit Company Information
13.14.2 Viwit Vildagliptin Product Portfolios and Specifications
13.14.3 Viwit Vildagliptin Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Viwit Main Business Overview
13.14.5 Viwit Latest Developments
13.15 Shanghai Acebright
13.15.1 Shanghai Acebright Company Information
13.15.2 Shanghai Acebright Vildagliptin Product Portfolios and Specifications
13.15.3 Shanghai Acebright Vildagliptin Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Shanghai Acebright Main Business Overview
13.15.5 Shanghai Acebright Latest Developments
13.16 Ningbo Menovo Pharma
13.16.1 Ningbo Menovo Pharma Company Information
13.16.2 Ningbo Menovo Pharma Vildagliptin Product Portfolios and Specifications
13.16.3 Ningbo Menovo Pharma Vildagliptin Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Ningbo Menovo Pharma Main Business Overview
13.16.5 Ningbo Menovo Pharma Latest Developments
13.17 Hangzhou Longshine Bio-Tech
13.17.1 Hangzhou Longshine Bio-Tech Company Information
13.17.2 Hangzhou Longshine Bio-Tech Vildagliptin Product Portfolios and Specifications
13.17.3 Hangzhou Longshine Bio-Tech Vildagliptin Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Hangzhou Longshine Bio-Tech Main Business Overview
13.17.5 Hangzhou Longshine Bio-Tech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vildagliptin Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Vildagliptin by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Vildagliptin by Country/Region, 2020, 2024 & 2031
2.2 Vildagliptin Segment by Type
2.2.1 Purity?98%
2.2.2 Purity?99%
2.3 Vildagliptin Sales by Type
2.3.1 Global Vildagliptin Sales Market Share by Type (2020-2025)
2.3.2 Global Vildagliptin Revenue and Market Share by Type (2020-2025)
2.3.3 Global Vildagliptin Sale Price by Type (2020-2025)
2.4 Vildagliptin Segment by Application
2.4.1 Vildagliptin Tablets
2.4.2 Other
2.5 Vildagliptin Sales by Application
2.5.1 Global Vildagliptin Sale Market Share by Application (2020-2025)
2.5.2 Global Vildagliptin Revenue and Market Share by Application (2020-2025)
2.5.3 Global Vildagliptin Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Vildagliptin Breakdown Data by Company
3.1.1 Global Vildagliptin Annual Sales by Company (2020-2025)
3.1.2 Global Vildagliptin Sales Market Share by Company (2020-2025)
3.2 Global Vildagliptin Annual Revenue by Company (2020-2025)
3.2.1 Global Vildagliptin Revenue by Company (2020-2025)
3.2.2 Global Vildagliptin Revenue Market Share by Company (2020-2025)
3.3 Global Vildagliptin Sale Price by Company
3.4 Key Manufacturers Vildagliptin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vildagliptin Product Location Distribution
3.4.2 Players Vildagliptin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VILDAGLIPTIN BY GEOGRAPHIC REGION
4.1 World Historic Vildagliptin Market Size by Geographic Region (2020-2025)
4.1.1 Global Vildagliptin Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Vildagliptin Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Vildagliptin Market Size by Country/Region (2020-2025)
4.2.1 Global Vildagliptin Annual Sales by Country/Region (2020-2025)
4.2.2 Global Vildagliptin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Vildagliptin Sales Growth
4.4 APAC Vildagliptin Sales Growth
4.5 Europe Vildagliptin Sales Growth
4.6 Middle East & Africa Vildagliptin Sales Growth
5 AMERICAS
5.1 Americas Vildagliptin Sales by Country
5.1.1 Americas Vildagliptin Sales by Country (2020-2025)
5.1.2 Americas Vildagliptin Revenue by Country (2020-2025)
5.2 Americas Vildagliptin Sales by Type (2020-2025)
5.3 Americas Vildagliptin Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vildagliptin Sales by Region
6.1.1 APAC Vildagliptin Sales by Region (2020-2025)
6.1.2 APAC Vildagliptin Revenue by Region (2020-2025)
6.2 APAC Vildagliptin Sales by Type (2020-2025)
6.3 APAC Vildagliptin Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vildagliptin by Country
7.1.1 Europe Vildagliptin Sales by Country (2020-2025)
7.1.2 Europe Vildagliptin Revenue by Country (2020-2025)
7.2 Europe Vildagliptin Sales by Type (2020-2025)
7.3 Europe Vildagliptin Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vildagliptin by Country
8.1.1 Middle East & Africa Vildagliptin Sales by Country (2020-2025)
8.1.2 Middle East & Africa Vildagliptin Revenue by Country (2020-2025)
8.2 Middle East & Africa Vildagliptin Sales by Type (2020-2025)
8.3 Middle East & Africa Vildagliptin Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vildagliptin
10.3 Manufacturing Process Analysis of Vildagliptin
10.4 Industry Chain Structure of Vildagliptin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vildagliptin Distributors
11.3 Vildagliptin Customer
12 WORLD FORECAST REVIEW FOR VILDAGLIPTIN BY GEOGRAPHIC REGION
12.1 Global Vildagliptin Market Size Forecast by Region
12.1.1 Global Vildagliptin Forecast by Region (2026-2031)
12.1.2 Global Vildagliptin Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Vildagliptin Forecast by Type (2026-2031)
12.7 Global Vildagliptin Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Hikal
13.1.1 Hikal Company Information
13.1.2 Hikal Vildagliptin Product Portfolios and Specifications
13.1.3 Hikal Vildagliptin Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Hikal Main Business Overview
13.1.5 Hikal Latest Developments
13.2 Jubilant Pharma
13.2.1 Jubilant Pharma Company Information
13.2.2 Jubilant Pharma Vildagliptin Product Portfolios and Specifications
13.2.3 Jubilant Pharma Vildagliptin Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Jubilant Pharma Main Business Overview
13.2.5 Jubilant Pharma Latest Developments
13.3 Glenmark Life Sciences
13.3.1 Glenmark Life Sciences Company Information
13.3.2 Glenmark Life Sciences Vildagliptin Product Portfolios and Specifications
13.3.3 Glenmark Life Sciences Vildagliptin Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Glenmark Life Sciences Main Business Overview
13.3.5 Glenmark Life Sciences Latest Developments
13.4 Chengda Pharmaceuticals
13.4.1 Chengda Pharmaceuticals Company Information
13.4.2 Chengda Pharmaceuticals Vildagliptin Product Portfolios and Specifications
13.4.3 Chengda Pharmaceuticals Vildagliptin Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Chengda Pharmaceuticals Main Business Overview
13.4.5 Chengda Pharmaceuticals Latest Developments
13.5 Fuxin Longrui Pharmaceutical
13.5.1 Fuxin Longrui Pharmaceutical Company Information
13.5.2 Fuxin Longrui Pharmaceutical Vildagliptin Product Portfolios and Specifications
13.5.3 Fuxin Longrui Pharmaceutical Vildagliptin Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Fuxin Longrui Pharmaceutical Main Business Overview
13.5.5 Fuxin Longrui Pharmaceutical Latest Developments
13.6 Jiangxi Synergy Pharma
13.6.1 Jiangxi Synergy Pharma Company Information
13.6.2 Jiangxi Synergy Pharma Vildagliptin Product Portfolios and Specifications
13.6.3 Jiangxi Synergy Pharma Vildagliptin Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Jiangxi Synergy Pharma Main Business Overview
13.6.5 Jiangxi Synergy Pharma Latest Developments
13.7 JSC Olainfarm
13.7.1 JSC Olainfarm Company Information
13.7.2 JSC Olainfarm Vildagliptin Product Portfolios and Specifications
13.7.3 JSC Olainfarm Vildagliptin Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 JSC Olainfarm Main Business Overview
13.7.5 JSC Olainfarm Latest Developments
13.8 Century Pharmaceuticals
13.8.1 Century Pharmaceuticals Company Information
13.8.2 Century Pharmaceuticals Vildagliptin Product Portfolios and Specifications
13.8.3 Century Pharmaceuticals Vildagliptin Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Century Pharmaceuticals Main Business Overview
13.8.5 Century Pharmaceuticals Latest Developments
13.9 Metrochem
13.9.1 Metrochem Company Information
13.9.2 Metrochem Vildagliptin Product Portfolios and Specifications
13.9.3 Metrochem Vildagliptin Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Metrochem Main Business Overview
13.9.5 Metrochem Latest Developments
13.10 TAGOOR LABORATORIES
13.10.1 TAGOOR LABORATORIES Company Information
13.10.2 TAGOOR LABORATORIES Vildagliptin Product Portfolios and Specifications
13.10.3 TAGOOR LABORATORIES Vildagliptin Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 TAGOOR LABORATORIES Main Business Overview
13.10.5 TAGOOR LABORATORIES Latest Developments
13.11 Biocon
13.11.1 Biocon Company Information
13.11.2 Biocon Vildagliptin Product Portfolios and Specifications
13.11.3 Biocon Vildagliptin Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Biocon Main Business Overview
13.11.5 Biocon Latest Developments
13.12 Kimia Biosciences
13.12.1 Kimia Biosciences Company Information
13.12.2 Kimia Biosciences Vildagliptin Product Portfolios and Specifications
13.12.3 Kimia Biosciences Vildagliptin Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Kimia Biosciences Main Business Overview
13.12.5 Kimia Biosciences Latest Developments
13.13 Lee Pharma
13.13.1 Lee Pharma Company Information
13.13.2 Lee Pharma Vildagliptin Product Portfolios and Specifications
13.13.3 Lee Pharma Vildagliptin Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Lee Pharma Main Business Overview
13.13.5 Lee Pharma Latest Developments
13.14 Viwit
13.14.1 Viwit Company Information
13.14.2 Viwit Vildagliptin Product Portfolios and Specifications
13.14.3 Viwit Vildagliptin Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Viwit Main Business Overview
13.14.5 Viwit Latest Developments
13.15 Shanghai Acebright
13.15.1 Shanghai Acebright Company Information
13.15.2 Shanghai Acebright Vildagliptin Product Portfolios and Specifications
13.15.3 Shanghai Acebright Vildagliptin Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Shanghai Acebright Main Business Overview
13.15.5 Shanghai Acebright Latest Developments
13.16 Ningbo Menovo Pharma
13.16.1 Ningbo Menovo Pharma Company Information
13.16.2 Ningbo Menovo Pharma Vildagliptin Product Portfolios and Specifications
13.16.3 Ningbo Menovo Pharma Vildagliptin Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Ningbo Menovo Pharma Main Business Overview
13.16.5 Ningbo Menovo Pharma Latest Developments
13.17 Hangzhou Longshine Bio-Tech
13.17.1 Hangzhou Longshine Bio-Tech Company Information
13.17.2 Hangzhou Longshine Bio-Tech Vildagliptin Product Portfolios and Specifications
13.17.3 Hangzhou Longshine Bio-Tech Vildagliptin Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Hangzhou Longshine Bio-Tech Main Business Overview
13.17.5 Hangzhou Longshine Bio-Tech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Vildagliptin Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Vildagliptin Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Purity?98%
Table 4. Major Players of Purity?99%
Table 5. Global Vildagliptin Sales by Type (2020-2025) & (Tons)
Table 6. Global Vildagliptin Sales Market Share by Type (2020-2025)
Table 7. Global Vildagliptin Revenue by Type (2020-2025) & ($ million)
Table 8. Global Vildagliptin Revenue Market Share by Type (2020-2025)
Table 9. Global Vildagliptin Sale Price by Type (2020-2025) & (US$/Kg)
Table 10. Global Vildagliptin Sale by Application (2020-2025) & (Tons)
Table 11. Global Vildagliptin Sale Market Share by Application (2020-2025)
Table 12. Global Vildagliptin Revenue by Application (2020-2025) & ($ million)
Table 13. Global Vildagliptin Revenue Market Share by Application (2020-2025)
Table 14. Global Vildagliptin Sale Price by Application (2020-2025) & (US$/Kg)
Table 15. Global Vildagliptin Sales by Company (2020-2025) & (Tons)
Table 16. Global Vildagliptin Sales Market Share by Company (2020-2025)
Table 17. Global Vildagliptin Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Vildagliptin Revenue Market Share by Company (2020-2025)
Table 19. Global Vildagliptin Sale Price by Company (2020-2025) & (US$/Kg)
Table 20. Key Manufacturers Vildagliptin Producing Area Distribution and Sales Area
Table 21. Players Vildagliptin Products Offered
Table 22. Vildagliptin Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Vildagliptin Sales by Geographic Region (2020-2025) & (Tons)
Table 26. Global Vildagliptin Sales Market Share Geographic Region (2020-2025)
Table 27. Global Vildagliptin Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Vildagliptin Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Vildagliptin Sales by Country/Region (2020-2025) & (Tons)
Table 30. Global Vildagliptin Sales Market Share by Country/Region (2020-2025)
Table 31. Global Vildagliptin Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Vildagliptin Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Vildagliptin Sales by Country (2020-2025) & (Tons)
Table 34. Americas Vildagliptin Sales Market Share by Country (2020-2025)
Table 35. Americas Vildagliptin Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Vildagliptin Sales by Type (2020-2025) & (Tons)
Table 37. Americas Vildagliptin Sales by Application (2020-2025) & (Tons)
Table 38. APAC Vildagliptin Sales by Region (2020-2025) & (Tons)
Table 39. APAC Vildagliptin Sales Market Share by Region (2020-2025)
Table 40. APAC Vildagliptin Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Vildagliptin Sales by Type (2020-2025) & (Tons)
Table 42. APAC Vildagliptin Sales by Application (2020-2025) & (Tons)
Table 43. Europe Vildagliptin Sales by Country (2020-2025) & (Tons)
Table 44. Europe Vildagliptin Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Vildagliptin Sales by Type (2020-2025) & (Tons)
Table 46. Europe Vildagliptin Sales by Application (2020-2025) & (Tons)
Table 47. Middle East & Africa Vildagliptin Sales by Country (2020-2025) & (Tons)
Table 48. Middle East & Africa Vildagliptin Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Vildagliptin Sales by Type (2020-2025) & (Tons)
Table 50. Middle East & Africa Vildagliptin Sales by Application (2020-2025) & (Tons)
Table 51. Key Market Drivers & Growth Opportunities of Vildagliptin
Table 52. Key Market Challenges & Risks of Vildagliptin
Table 53. Key Industry Trends of Vildagliptin
Table 54. Vildagliptin Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Vildagliptin Distributors List
Table 57. Vildagliptin Customer List
Table 58. Global Vildagliptin Sales Forecast by Region (2026-2031) & (Tons)
Table 59. Global Vildagliptin Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Vildagliptin Sales Forecast by Country (2026-2031) & (Tons)
Table 61. Americas Vildagliptin Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Vildagliptin Sales Forecast by Region (2026-2031) & (Tons)
Table 63. APAC Vildagliptin Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Vildagliptin Sales Forecast by Country (2026-2031) & (Tons)
Table 65. Europe Vildagliptin Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Vildagliptin Sales Forecast by Country (2026-2031) & (Tons)
Table 67. Middle East & Africa Vildagliptin Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Vildagliptin Sales Forecast by Type (2026-2031) & (Tons)
Table 69. Global Vildagliptin Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Vildagliptin Sales Forecast by Application (2026-2031) & (Tons)
Table 71. Global Vildagliptin Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Hikal Basic Information, Vildagliptin Manufacturing Base, Sales Area and Its Competitors
Table 73. Hikal Vildagliptin Product Portfolios and Specifications
Table 74. Hikal Vildagliptin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 75. Hikal Main Business
Table 76. Hikal Latest Developments
Table 77. Jubilant Pharma Basic Information, Vildagliptin Manufacturing Base, Sales Area and Its Competitors
Table 78. Jubilant Pharma Vildagliptin Product Portfolios and Specifications
Table 79. Jubilant Pharma Vildagliptin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 80. Jubilant Pharma Main Business
Table 81. Jubilant Pharma Latest Developments
Table 82. Glenmark Life Sciences Basic Information, Vildagliptin Manufacturing Base, Sales Area and Its Competitors
Table 83. Glenmark Life Sciences Vildagliptin Product Portfolios and Specifications
Table 84. Glenmark Life Sciences Vildagliptin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 85. Glenmark Life Sciences Main Business
Table 86. Glenmark Life Sciences Latest Developments
Table 87. Chengda Pharmaceuticals Basic Information, Vildagliptin Manufacturing Base, Sales Area and Its Competitors
Table 88. Chengda Pharmaceuticals Vildagliptin Product Portfolios and Specifications
Table 89. Chengda Pharmaceuticals Vildagliptin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 90. Chengda Pharmaceuticals Main Business
Table 91. Chengda Pharmaceuticals Latest Developments
Table 92. Fuxin Longrui Pharmaceutical Basic Information, Vildagliptin Manufacturing Base, Sales Area and Its Competitors
Table 93. Fuxin Longrui Pharmaceutical Vildagliptin Product Portfolios and Specifications
Table 94. Fuxin Longrui Pharmaceutical Vildagliptin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 95. Fuxin Longrui Pharmaceutical Main Business
Table 96. Fuxin Longrui Pharmaceutical Latest Developments
Table 97. Jiangxi Synergy Pharma Basic Information, Vildagliptin Manufacturing Base, Sales Area and Its Competitors
Table 98. Jiangxi Synergy Pharma Vildagliptin Product Portfolios and Specifications
Table 99. Jiangxi Synergy Pharma Vildagliptin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 100. Jiangxi Synergy Pharma Main Business
Table 101. Jiangxi Synergy Pharma Latest Developments
Table 102. JSC Olainfarm Basic Information, Vildagliptin Manufacturing Base, Sales Area and Its Competitors
Table 103. JSC Olainfarm Vildagliptin Product Portfolios and Specifications
Table 104. JSC Olainfarm Vildagliptin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 105. JSC Olainfarm Main Business
Table 106. JSC Olainfarm Latest Developments
Table 107. Century Pharmaceuticals Basic Information, Vildagliptin Manufacturing Base, Sales Area and Its Competitors
Table 108. Century Pharmaceuticals Vildagliptin Product Portfolios and Specifications
Table 109. Century Pharmaceuticals Vildagliptin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 110. Century Pharmaceuticals Main Business
Table 111. Century Pharmaceuticals Latest Developments
Table 112. Metrochem Basic Information, Vildagliptin Manufacturing Base, Sales Area and Its Competitors
Table 113. Metrochem Vildagliptin Product Portfolios and Specifications
Table 114. Metrochem Vildagliptin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 115. Metrochem Main Business
Table 116. Metrochem Latest Developments
Table 117. TAGOOR LABORATORIES Basic Information, Vildagliptin Manufacturing Base, Sales Area and Its Competitors
Table 118. TAGOOR LABORATORIES Vildagliptin Product Portfolios and Specifications
Table 119. TAGOOR LABORATORIES Vildagliptin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 120. TAGOOR LABORATORIES Main Business
Table 121. TAGOOR LABORATORIES Latest Developments
Table 122. Biocon Basic Information, Vildagliptin Manufacturing Base, Sales Area and Its Competitors
Table 123. Biocon Vildagliptin Product Portfolios and Specifications
Table 124. Biocon Vildagliptin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 125. Biocon Main Business
Table 126. Biocon Latest Developments
Table 127. Kimia Biosciences Basic Information, Vildagliptin Manufacturing Base, Sales Area and Its Competitors
Table 128. Kimia Biosciences Vildagliptin Product Portfolios and Specifications
Table 129. Kimia Biosciences Vildagliptin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 130. Kimia Biosciences Main Business
Table 131. Kimia Biosciences Latest Developments
Table 132. Lee Pharma Basic Information, Vildagliptin Manufacturing Base, Sales Area and Its Competitors
Table 133. Lee Pharma Vildagliptin Product Portfolios and Specifications
Table 134. Lee Pharma Vildagliptin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 135. Lee Pharma Main Business
Table 136. Lee Pharma Latest Developments
Table 137. Viwit Basic Information, Vildagliptin Manufacturing Base, Sales Area and Its Competitors
Table 138. Viwit Vildagliptin Product Portfolios and Specifications
Table 139. Viwit Vildagliptin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 140. Viwit Main Business
Table 141. Viwit Latest Developments
Table 142. Shanghai Acebright Basic Information, Vildagliptin Manufacturing Base, Sales Area and Its Competitors
Table 143. Shanghai Acebright Vildagliptin Product Portfolios and Specifications
Table 144. Shanghai Acebright Vildagliptin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 145. Shanghai Acebright Main Business
Table 146. Shanghai Acebright Latest Developments
Table 147. Ningbo Menovo Pharma Basic Information, Vildagliptin Manufacturing Base, Sales Area and Its Competitors
Table 148. Ningbo Menovo Pharma Vildagliptin Product Portfolios and Specifications
Table 149. Ningbo Menovo Pharma Vildagliptin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 150. Ningbo Menovo Pharma Main Business
Table 151. Ningbo Menovo Pharma Latest Developments
Table 152. Hangzhou Longshine Bio-Tech Basic Information, Vildagliptin Manufacturing Base, Sales Area and Its Competitors
Table 153. Hangzhou Longshine Bio-Tech Vildagliptin Product Portfolios and Specifications
Table 154. Hangzhou Longshine Bio-Tech Vildagliptin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 155. Hangzhou Longshine Bio-Tech Main Business
Table 156. Hangzhou Longshine Bio-Tech Latest Developments
Table 1. Vildagliptin Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Vildagliptin Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Purity?98%
Table 4. Major Players of Purity?99%
Table 5. Global Vildagliptin Sales by Type (2020-2025) & (Tons)
Table 6. Global Vildagliptin Sales Market Share by Type (2020-2025)
Table 7. Global Vildagliptin Revenue by Type (2020-2025) & ($ million)
Table 8. Global Vildagliptin Revenue Market Share by Type (2020-2025)
Table 9. Global Vildagliptin Sale Price by Type (2020-2025) & (US$/Kg)
Table 10. Global Vildagliptin Sale by Application (2020-2025) & (Tons)
Table 11. Global Vildagliptin Sale Market Share by Application (2020-2025)
Table 12. Global Vildagliptin Revenue by Application (2020-2025) & ($ million)
Table 13. Global Vildagliptin Revenue Market Share by Application (2020-2025)
Table 14. Global Vildagliptin Sale Price by Application (2020-2025) & (US$/Kg)
Table 15. Global Vildagliptin Sales by Company (2020-2025) & (Tons)
Table 16. Global Vildagliptin Sales Market Share by Company (2020-2025)
Table 17. Global Vildagliptin Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Vildagliptin Revenue Market Share by Company (2020-2025)
Table 19. Global Vildagliptin Sale Price by Company (2020-2025) & (US$/Kg)
Table 20. Key Manufacturers Vildagliptin Producing Area Distribution and Sales Area
Table 21. Players Vildagliptin Products Offered
Table 22. Vildagliptin Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Vildagliptin Sales by Geographic Region (2020-2025) & (Tons)
Table 26. Global Vildagliptin Sales Market Share Geographic Region (2020-2025)
Table 27. Global Vildagliptin Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Vildagliptin Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Vildagliptin Sales by Country/Region (2020-2025) & (Tons)
Table 30. Global Vildagliptin Sales Market Share by Country/Region (2020-2025)
Table 31. Global Vildagliptin Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Vildagliptin Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Vildagliptin Sales by Country (2020-2025) & (Tons)
Table 34. Americas Vildagliptin Sales Market Share by Country (2020-2025)
Table 35. Americas Vildagliptin Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Vildagliptin Sales by Type (2020-2025) & (Tons)
Table 37. Americas Vildagliptin Sales by Application (2020-2025) & (Tons)
Table 38. APAC Vildagliptin Sales by Region (2020-2025) & (Tons)
Table 39. APAC Vildagliptin Sales Market Share by Region (2020-2025)
Table 40. APAC Vildagliptin Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Vildagliptin Sales by Type (2020-2025) & (Tons)
Table 42. APAC Vildagliptin Sales by Application (2020-2025) & (Tons)
Table 43. Europe Vildagliptin Sales by Country (2020-2025) & (Tons)
Table 44. Europe Vildagliptin Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Vildagliptin Sales by Type (2020-2025) & (Tons)
Table 46. Europe Vildagliptin Sales by Application (2020-2025) & (Tons)
Table 47. Middle East & Africa Vildagliptin Sales by Country (2020-2025) & (Tons)
Table 48. Middle East & Africa Vildagliptin Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Vildagliptin Sales by Type (2020-2025) & (Tons)
Table 50. Middle East & Africa Vildagliptin Sales by Application (2020-2025) & (Tons)
Table 51. Key Market Drivers & Growth Opportunities of Vildagliptin
Table 52. Key Market Challenges & Risks of Vildagliptin
Table 53. Key Industry Trends of Vildagliptin
Table 54. Vildagliptin Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Vildagliptin Distributors List
Table 57. Vildagliptin Customer List
Table 58. Global Vildagliptin Sales Forecast by Region (2026-2031) & (Tons)
Table 59. Global Vildagliptin Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Vildagliptin Sales Forecast by Country (2026-2031) & (Tons)
Table 61. Americas Vildagliptin Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Vildagliptin Sales Forecast by Region (2026-2031) & (Tons)
Table 63. APAC Vildagliptin Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Vildagliptin Sales Forecast by Country (2026-2031) & (Tons)
Table 65. Europe Vildagliptin Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Vildagliptin Sales Forecast by Country (2026-2031) & (Tons)
Table 67. Middle East & Africa Vildagliptin Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Vildagliptin Sales Forecast by Type (2026-2031) & (Tons)
Table 69. Global Vildagliptin Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Vildagliptin Sales Forecast by Application (2026-2031) & (Tons)
Table 71. Global Vildagliptin Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Hikal Basic Information, Vildagliptin Manufacturing Base, Sales Area and Its Competitors
Table 73. Hikal Vildagliptin Product Portfolios and Specifications
Table 74. Hikal Vildagliptin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 75. Hikal Main Business
Table 76. Hikal Latest Developments
Table 77. Jubilant Pharma Basic Information, Vildagliptin Manufacturing Base, Sales Area and Its Competitors
Table 78. Jubilant Pharma Vildagliptin Product Portfolios and Specifications
Table 79. Jubilant Pharma Vildagliptin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 80. Jubilant Pharma Main Business
Table 81. Jubilant Pharma Latest Developments
Table 82. Glenmark Life Sciences Basic Information, Vildagliptin Manufacturing Base, Sales Area and Its Competitors
Table 83. Glenmark Life Sciences Vildagliptin Product Portfolios and Specifications
Table 84. Glenmark Life Sciences Vildagliptin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 85. Glenmark Life Sciences Main Business
Table 86. Glenmark Life Sciences Latest Developments
Table 87. Chengda Pharmaceuticals Basic Information, Vildagliptin Manufacturing Base, Sales Area and Its Competitors
Table 88. Chengda Pharmaceuticals Vildagliptin Product Portfolios and Specifications
Table 89. Chengda Pharmaceuticals Vildagliptin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 90. Chengda Pharmaceuticals Main Business
Table 91. Chengda Pharmaceuticals Latest Developments
Table 92. Fuxin Longrui Pharmaceutical Basic Information, Vildagliptin Manufacturing Base, Sales Area and Its Competitors
Table 93. Fuxin Longrui Pharmaceutical Vildagliptin Product Portfolios and Specifications
Table 94. Fuxin Longrui Pharmaceutical Vildagliptin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 95. Fuxin Longrui Pharmaceutical Main Business
Table 96. Fuxin Longrui Pharmaceutical Latest Developments
Table 97. Jiangxi Synergy Pharma Basic Information, Vildagliptin Manufacturing Base, Sales Area and Its Competitors
Table 98. Jiangxi Synergy Pharma Vildagliptin Product Portfolios and Specifications
Table 99. Jiangxi Synergy Pharma Vildagliptin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 100. Jiangxi Synergy Pharma Main Business
Table 101. Jiangxi Synergy Pharma Latest Developments
Table 102. JSC Olainfarm Basic Information, Vildagliptin Manufacturing Base, Sales Area and Its Competitors
Table 103. JSC Olainfarm Vildagliptin Product Portfolios and Specifications
Table 104. JSC Olainfarm Vildagliptin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 105. JSC Olainfarm Main Business
Table 106. JSC Olainfarm Latest Developments
Table 107. Century Pharmaceuticals Basic Information, Vildagliptin Manufacturing Base, Sales Area and Its Competitors
Table 108. Century Pharmaceuticals Vildagliptin Product Portfolios and Specifications
Table 109. Century Pharmaceuticals Vildagliptin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 110. Century Pharmaceuticals Main Business
Table 111. Century Pharmaceuticals Latest Developments
Table 112. Metrochem Basic Information, Vildagliptin Manufacturing Base, Sales Area and Its Competitors
Table 113. Metrochem Vildagliptin Product Portfolios and Specifications
Table 114. Metrochem Vildagliptin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 115. Metrochem Main Business
Table 116. Metrochem Latest Developments
Table 117. TAGOOR LABORATORIES Basic Information, Vildagliptin Manufacturing Base, Sales Area and Its Competitors
Table 118. TAGOOR LABORATORIES Vildagliptin Product Portfolios and Specifications
Table 119. TAGOOR LABORATORIES Vildagliptin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 120. TAGOOR LABORATORIES Main Business
Table 121. TAGOOR LABORATORIES Latest Developments
Table 122. Biocon Basic Information, Vildagliptin Manufacturing Base, Sales Area and Its Competitors
Table 123. Biocon Vildagliptin Product Portfolios and Specifications
Table 124. Biocon Vildagliptin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 125. Biocon Main Business
Table 126. Biocon Latest Developments
Table 127. Kimia Biosciences Basic Information, Vildagliptin Manufacturing Base, Sales Area and Its Competitors
Table 128. Kimia Biosciences Vildagliptin Product Portfolios and Specifications
Table 129. Kimia Biosciences Vildagliptin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 130. Kimia Biosciences Main Business
Table 131. Kimia Biosciences Latest Developments
Table 132. Lee Pharma Basic Information, Vildagliptin Manufacturing Base, Sales Area and Its Competitors
Table 133. Lee Pharma Vildagliptin Product Portfolios and Specifications
Table 134. Lee Pharma Vildagliptin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 135. Lee Pharma Main Business
Table 136. Lee Pharma Latest Developments
Table 137. Viwit Basic Information, Vildagliptin Manufacturing Base, Sales Area and Its Competitors
Table 138. Viwit Vildagliptin Product Portfolios and Specifications
Table 139. Viwit Vildagliptin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 140. Viwit Main Business
Table 141. Viwit Latest Developments
Table 142. Shanghai Acebright Basic Information, Vildagliptin Manufacturing Base, Sales Area and Its Competitors
Table 143. Shanghai Acebright Vildagliptin Product Portfolios and Specifications
Table 144. Shanghai Acebright Vildagliptin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 145. Shanghai Acebright Main Business
Table 146. Shanghai Acebright Latest Developments
Table 147. Ningbo Menovo Pharma Basic Information, Vildagliptin Manufacturing Base, Sales Area and Its Competitors
Table 148. Ningbo Menovo Pharma Vildagliptin Product Portfolios and Specifications
Table 149. Ningbo Menovo Pharma Vildagliptin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 150. Ningbo Menovo Pharma Main Business
Table 151. Ningbo Menovo Pharma Latest Developments
Table 152. Hangzhou Longshine Bio-Tech Basic Information, Vildagliptin Manufacturing Base, Sales Area and Its Competitors
Table 153. Hangzhou Longshine Bio-Tech Vildagliptin Product Portfolios and Specifications
Table 154. Hangzhou Longshine Bio-Tech Vildagliptin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 155. Hangzhou Longshine Bio-Tech Main Business
Table 156. Hangzhou Longshine Bio-Tech Latest Developments
LIST OF FIGURES
Figure 1. Picture of Vildagliptin
Figure 2. Vildagliptin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vildagliptin Sales Growth Rate 2020-2031 (Tons)
Figure 7. Global Vildagliptin Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Vildagliptin Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Vildagliptin Sales Market Share by Country/Region (2024)
Figure 10. Vildagliptin Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Purity?98%
Figure 12. Product Picture of Purity?99%
Figure 13. Global Vildagliptin Sales Market Share by Type in 2025
Figure 14. Global Vildagliptin Revenue Market Share by Type (2020-2025)
Figure 15. Vildagliptin Consumed in VildagliptinTablets
Figure 16. Global Vildagliptin Market: VildagliptinTablets (2020-2025) & (Tons)
Figure 17. Vildagliptin Consumed in Other
Figure 18. Global Vildagliptin Market: Other (2020-2025) & (Tons)
Figure 19. Global Vildagliptin Sale Market Share by Application (2024)
Figure 20. Global Vildagliptin Revenue Market Share by Application in 2025
Figure 21. Vildagliptin Sales by Company in 2025 (Tons)
Figure 22. Global Vildagliptin Sales Market Share by Company in 2025
Figure 23. Vildagliptin Revenue by Company in 2025 ($ millions)
Figure 24. Global Vildagliptin Revenue Market Share by Company in 2025
Figure 25. Global Vildagliptin Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Vildagliptin Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Vildagliptin Sales 2020-2025 (Tons)
Figure 28. Americas Vildagliptin Revenue 2020-2025 ($ millions)
Figure 29. APAC Vildagliptin Sales 2020-2025 (Tons)
Figure 30. APAC Vildagliptin Revenue 2020-2025 ($ millions)
Figure 31. Europe Vildagliptin Sales 2020-2025 (Tons)
Figure 32. Europe Vildagliptin Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Vildagliptin Sales 2020-2025 (Tons)
Figure 34. Middle East & Africa Vildagliptin Revenue 2020-2025 ($ millions)
Figure 35. Americas Vildagliptin Sales Market Share by Country in 2025
Figure 36. Americas Vildagliptin Revenue Market Share by Country (2020-2025)
Figure 37. Americas Vildagliptin Sales Market Share by Type (2020-2025)
Figure 38. Americas Vildagliptin Sales Market Share by Application (2020-2025)
Figure 39. United States Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Vildagliptin Sales Market Share by Region in 2025
Figure 44. APAC Vildagliptin Revenue Market Share by Region (2020-2025)
Figure 45. APAC Vildagliptin Sales Market Share by Type (2020-2025)
Figure 46. APAC Vildagliptin Sales Market Share by Application (2020-2025)
Figure 47. China Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 51. India Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Vildagliptin Sales Market Share by Country in 2025
Figure 55. Europe Vildagliptin Revenue Market Share by Country (2020-2025)
Figure 56. Europe Vildagliptin Sales Market Share by Type (2020-2025)
Figure 57. Europe Vildagliptin Sales Market Share by Application (2020-2025)
Figure 58. Germany Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 59. France Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Vildagliptin Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Vildagliptin Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Vildagliptin Sales Market Share by Application (2020-2025)
Figure 66. Egypt Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Vildagliptin in 2025
Figure 72. Manufacturing Process Analysis of Vildagliptin
Figure 73. Industry Chain Structure of Vildagliptin
Figure 74. Channels of Distribution
Figure 75. Global Vildagliptin Sales Market Forecast by Region (2026-2031)
Figure 76. Global Vildagliptin Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Vildagliptin Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Vildagliptin Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Vildagliptin Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Vildagliptin Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Vildagliptin
Figure 2. Vildagliptin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vildagliptin Sales Growth Rate 2020-2031 (Tons)
Figure 7. Global Vildagliptin Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Vildagliptin Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Vildagliptin Sales Market Share by Country/Region (2024)
Figure 10. Vildagliptin Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Purity?98%
Figure 12. Product Picture of Purity?99%
Figure 13. Global Vildagliptin Sales Market Share by Type in 2025
Figure 14. Global Vildagliptin Revenue Market Share by Type (2020-2025)
Figure 15. Vildagliptin Consumed in VildagliptinTablets
Figure 16. Global Vildagliptin Market: VildagliptinTablets (2020-2025) & (Tons)
Figure 17. Vildagliptin Consumed in Other
Figure 18. Global Vildagliptin Market: Other (2020-2025) & (Tons)
Figure 19. Global Vildagliptin Sale Market Share by Application (2024)
Figure 20. Global Vildagliptin Revenue Market Share by Application in 2025
Figure 21. Vildagliptin Sales by Company in 2025 (Tons)
Figure 22. Global Vildagliptin Sales Market Share by Company in 2025
Figure 23. Vildagliptin Revenue by Company in 2025 ($ millions)
Figure 24. Global Vildagliptin Revenue Market Share by Company in 2025
Figure 25. Global Vildagliptin Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Vildagliptin Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Vildagliptin Sales 2020-2025 (Tons)
Figure 28. Americas Vildagliptin Revenue 2020-2025 ($ millions)
Figure 29. APAC Vildagliptin Sales 2020-2025 (Tons)
Figure 30. APAC Vildagliptin Revenue 2020-2025 ($ millions)
Figure 31. Europe Vildagliptin Sales 2020-2025 (Tons)
Figure 32. Europe Vildagliptin Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Vildagliptin Sales 2020-2025 (Tons)
Figure 34. Middle East & Africa Vildagliptin Revenue 2020-2025 ($ millions)
Figure 35. Americas Vildagliptin Sales Market Share by Country in 2025
Figure 36. Americas Vildagliptin Revenue Market Share by Country (2020-2025)
Figure 37. Americas Vildagliptin Sales Market Share by Type (2020-2025)
Figure 38. Americas Vildagliptin Sales Market Share by Application (2020-2025)
Figure 39. United States Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Vildagliptin Sales Market Share by Region in 2025
Figure 44. APAC Vildagliptin Revenue Market Share by Region (2020-2025)
Figure 45. APAC Vildagliptin Sales Market Share by Type (2020-2025)
Figure 46. APAC Vildagliptin Sales Market Share by Application (2020-2025)
Figure 47. China Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 51. India Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Vildagliptin Sales Market Share by Country in 2025
Figure 55. Europe Vildagliptin Revenue Market Share by Country (2020-2025)
Figure 56. Europe Vildagliptin Sales Market Share by Type (2020-2025)
Figure 57. Europe Vildagliptin Sales Market Share by Application (2020-2025)
Figure 58. Germany Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 59. France Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Vildagliptin Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Vildagliptin Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Vildagliptin Sales Market Share by Application (2020-2025)
Figure 66. Egypt Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Vildagliptin Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Vildagliptin in 2025
Figure 72. Manufacturing Process Analysis of Vildagliptin
Figure 73. Industry Chain Structure of Vildagliptin
Figure 74. Channels of Distribution
Figure 75. Global Vildagliptin Sales Market Forecast by Region (2026-2031)
Figure 76. Global Vildagliptin Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Vildagliptin Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Vildagliptin Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Vildagliptin Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Vildagliptin Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Flax Yarns Market Growth 2025-2031
US$ 3,660.00
October 2025
113 pages
Global Structural Bolts Market Growth 2026-2032
US$ 3,660.00
October 2026
146 pages
Global Rubber Bulb Seals Market Growth 2025-2031
US$ 3,660.00
September 2025
143 pages
